AB Science S.A. (EPA:AB)
0.6930
0.00 (0.00%)
Aug 21, 2026, 5:35 PM CET
AB Science Market Cap
AB Science has a market cap or net worth of €55.45 million as of August 21, 2026. Its market cap has decreased by -38.29% in one year.
Market Cap
55.45M
Enterprise Value
64.72M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.69
ChartMarket Cap Chart
Since April 26, 2010, AB Science's market cap has decreased from 381.93M to 55.45M, a decrease of -85.48%. That is a compound annual growth rate of -11.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 55.45M | -50.51% |
| Dec 31, 2025 | 112.05M | 94.70% |
| Dec 31, 2024 | 57.55M | -68.19% |
| Dec 29, 2023 | 180.92M | -45.55% |
| Dec 30, 2022 | 332.25M | -40.91% |
| Dec 31, 2021 | 562.31M | -37.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 94.12B |
| EssilorLuxottica Société anonyme | 75.12B |
| Sartorius Stedim Biotech | 17.80B |
| Ipsen | 13.54B |
| ABIONYX Pharma | 68.12M |
| THX Pharma Société Anonyme | 60.84M |
| MaaT Pharma | 59.36M |
| Theraclion | 47.89M |